Rijksinstituut voor Volksgezondheid en Milieu Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort | RIVM Jaar: 2017 Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort | RIVM Bron: rivm.nl Download dossier (ZIP) · JSON